Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Predictive model for epileptogenic tubers from all tubers in patients with tuberous sclerosis complex based on 18F-FDG PET: an 8-year single-centre study

Fig. 4

Decision curve and clinical impact curve show identification probability of epileptogenic tubers using nomogram. A Decision curve for the probability of identifying epileptogenic tubers using nomogram. The net benefits were measured at different threshold probabilities. The blue line represents the identification nomogram. The gray line represents the assumption that all tubers are identified as epileptogenic tubers. The black line represents the assumption that no tubers are identified as epileptogenic tubers. B Clinical impact curve to identify the epileptogenic tubers for a population size of 1000. The red curve shows the identified number of epileptogenic tubers at different threshold probabilities, and the blue curve represents actual number of epileptogenic tubers

Back to article page